These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8482278

  • 1. Cytokines predict coronary aneurysm formation in Kawasaki disease patients.
    Lin CY, Lin CC, Hwang B, Chiang BN.
    Eur J Pediatr; 1993 Apr; 152(4):309-12. PubMed ID: 8482278
    [Abstract] [Full Text] [Related]

  • 2. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S, Evereklioglu C, Er H, Türköz Y, Sevinç A, Mehmet N, Savli H.
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [Abstract] [Full Text] [Related]

  • 3. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.
    Lin CY, Lin CC, Hwang B, Chiang B.
    J Pediatr; 1992 Dec; 121(6):924-6. PubMed ID: 1447658
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C, Er H, Türköz Y, Cekmen M.
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [Abstract] [Full Text] [Related]

  • 5. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
    [Abstract] [Full Text] [Related]

  • 6. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.
    Mangge H, Kenzian H, Gallistl S, Neuwirth G, Liebmann P, Kaulfersch W, Beaufort F, Muntean W, Schauenstein K.
    Arthritis Rheum; 1995 Feb; 38(2):211-20. PubMed ID: 7848311
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions.
    Matsubara T, Furukawa S, Yabuta K.
    Clin Immunol Immunopathol; 1990 Jul; 56(1):29-36. PubMed ID: 2113446
    [Abstract] [Full Text] [Related]

  • 8. Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis.
    Bal A, Unlu E, Bahar G, Aydog E, Eksioglu E, Yorgancioglu R.
    Clin Rheumatol; 2007 Feb; 26(2):211-5. PubMed ID: 16583185
    [Abstract] [Full Text] [Related]

  • 9. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
    Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann-Liang R.
    J Clin Immunol; 2001 May; 21(3):193-9. PubMed ID: 11403226
    [Abstract] [Full Text] [Related]

  • 10. The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease.
    Lin CY, Lin CC, Hwang B, Chiang BN.
    Eur J Pediatr; 1991 Jan; 150(3):179-82. PubMed ID: 1904353
    [Abstract] [Full Text] [Related]

  • 11. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.
    Liu Y, Ho RC, Mak A.
    J Affect Disord; 2012 Aug; 139(3):230-9. PubMed ID: 21872339
    [Abstract] [Full Text] [Related]

  • 12. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
    Erbağci AB, Herken H, Köylüoglu O, Yilmaz N, Tarakçioglu M.
    Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
    [Abstract] [Full Text] [Related]

  • 13. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X, Blade J, Guillermo AL, Molina R, Rozman C, Ballesta AM.
    Cancer Detect Prev; 1996 Jun; 20(1):52-6. PubMed ID: 8907203
    [Abstract] [Full Text] [Related]

  • 14. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.
    Si F, Wu Y, Gao F, Feng S, Liu R, Yi Q.
    Clin Exp Med; 2017 Nov; 17(4):451-457. PubMed ID: 28108813
    [Abstract] [Full Text] [Related]

  • 15. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
    Peter JB, Boctor FN, Tourtellotte WW.
    Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
    [Abstract] [Full Text] [Related]

  • 16. Serum and urinary interleukin-6 (IL-6) levels as predicting factors of Kawasaki disease activity.
    Chow YM, Lin CY, Hwang B.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993 Jan; 34(2):77-83. PubMed ID: 8372675
    [Abstract] [Full Text] [Related]

  • 17. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
    Barrera P, Boerbooms AM, Janssen EM, Sauerwein RW, Gallati H, Mulder J, de Boo T, Demacker PN, van de Putte LB, van der Meer JW.
    Arthritis Rheum; 1993 Aug; 36(8):1070-9. PubMed ID: 8393676
    [Abstract] [Full Text] [Related]

  • 18. Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies.
    Raziuddin S, Sheikha A, Abu-Eshy S, al-Janadi M.
    Cancer; 1994 May 01; 73(9):2426-31. PubMed ID: 8168046
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
    Scott-Algara D, Vuillier F, Marasescu M, de Saint Martin J, Dighiero G.
    AIDS Res Hum Retroviruses; 1991 Apr 01; 7(4):381-6. PubMed ID: 1676897
    [Abstract] [Full Text] [Related]

  • 20. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.
    Kart L, Buyukoglan H, Tekin IO, Altin R, Senturk Z, Gulmez I, Demir R, Ozesmi M.
    Mediators Inflamm; 2003 Feb 01; 12(1):9-14. PubMed ID: 12745543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.